Galapagos NV

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. 5.53%219.760.0%$1925.11m
BIIBBiogen, Inc. -1.78%374.131.7%$1311.23m
SNSSSunesis Pharmaceuticals, Inc. -7.49%11.860.7%$829.06m
NVAXNovavax, Inc. 6.42%192.6079.8%$798.79m
AMGNAmgen, Inc. -0.44%239.181.3%$660.54m
BNTXBioNTech SE 3.76%234.600.0%$573.76m
VRTXVertex Pharmaceuticals, Inc. 0.18%188.041.9%$535.06m
GILDGilead Sciences, Inc. -0.61%66.941.0%$494.97m
REGNRegeneron Pharmaceuticals, Inc. -0.25%532.962.7%$387.46m
ILMNIllumina, Inc. 0.81%464.793.5%$352.20m
ALXNAlexion Pharmaceuticals, Inc. -0.56%179.652.0%$338.01m
OCGNOcugen, Inc. -5.41%7.000.0%$324.15m
TXG10X Genomics, Inc. 0.82%199.500.0%$178.80m
EXASEXACT Sciences Corp. 0.98%128.9118.1%$178.13m
TECHBio-Techne Corp. -0.11%439.754.5%$163.67m

Company Profile

Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. It operates through the Research & Development and Fee-for-Services segment. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium.